| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
785,947,000 |
| Market
Cap: |
141.47(M) |
| Last
Volume: |
380,911 |
Avg
Vol: |
832,220 |
| 52
Week Range: |
$0.0328 - $0.205 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Elite Pharmaceuticals is a pharmaceutical company. Co. owns, licenses or contracts manufacture various products that are being sold commercially, including: bariatric products, which include Phentermine HCl 37.5mg tablets and Phendimetrazine Tartrate 35mg tablets; pain products, which include Naltrexone HCl 50mg tablets and Oxycodone HCl Immediate Release five mg, 10mg, 15mg, 20mg and 30mg tablets; cardiovascular product, which includes Isradipine 2.5mg and five mg capsules; antidepressant product, which includes Trimipramine Maleate Immediate Release 25mg, 50mg and 100mg capsules; and muscle relaxant product, which includes Dantrolene Sodium Capsules 25mg, 50mg and 100mg.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Whitnell Jeffrey A |
Director |
– • – |
2015-03-05 |
4 |
A |
$0.34 |
$19,998 |
D/D |
58,475 |
1,035,874 |
|
- |
|
| Dash Barry H |
Director |
– • – |
2015-03-05 |
4 |
A |
$0.34 |
$19,998 |
D/D |
58,475 |
1,084,229 |
|
- |
|
| Treppel Jerry |
Chairman of Board |
• • – |
2015-03-05 |
4 |
A |
$0.34 |
$29,997 |
D/D |
87,711 |
9,354,269 |
|
- |
|
| Ward Carter Julian |
CFO, Secretary, Treasurer |
• – – |
2015-03-05 |
4 |
A |
$0.34 |
$29,997 |
D/D |
87,711 |
963,293 |
|
- |
|
| Hakim Nasrat A |
President & CEO |
• • • |
2015-03-05 |
4 |
A |
$0.34 |
$699,921 |
D/D |
2,046,554 |
13,760,695 |
|
- |
|
| Plassche Douglas |
Executive VP of Operations |
• – – |
2015-02-27 |
5 |
A |
$0.34 |
$24,998 |
D/D |
73,094 |
158,624 |
|
- |
|
| Nigalaye Ashok G |
Chief Scientific Officer |
• • • |
2015-01-06 |
4 |
OE |
$0.06 |
$177,083 |
D/D |
2,833,333 |
17,108,622 |
|
- |
|
| Hakim Nasrat A |
CEO & President |
• • – |
2014-09-26 |
4 |
B |
$0.31 |
$82,385 |
I/I |
265,500 |
2,700,000 |
2.66 |
- |
|
| Hakim Nasrat A |
CEO & President |
• • – |
2014-09-25 |
4 |
B |
$0.31 |
$133,956 |
I/I |
434,500 |
2,434,500 |
2.66 |
- |
|
| Treppel Jerry |
Chairman of the Board |
• • – |
2014-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,060,000 |
9,266,558 |
|
- |
|
| Treppel Jerry |
Chairman of the Board |
• • – |
2014-06-17 |
4 |
OE |
$0.25 |
$93,750 |
D/D |
375,000 |
3,206,558 |
|
- |
|
86 Records found
|
|
Page 4 of 4 |
|
|
